Medication info

Emplom 5/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablet with a yellow color that has a brownish tint
Packaging
10 tablets/box [(10 tablets/PTP)×1], 60 tablets/box [(10 tablets/PTP)×6], 60 tablets/bottle
Approval status
Active

MFDS item code 202201376 · Approved 2022.04.04

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular diseases
  • cardiovascular events
View approved original text

This medication helps improve blood sugar control in adult patients with type 2 diabetes when used in conjunction with dietary and exercise therapy. It is particularly effective when used in combination with metformin and empagliflozin. Furthermore, it should be used cautiously in adult type 2 diabetes patients with cardiovascular diseases who are not achieving adequate blood sugar control, keeping in mind the risk of cardiovascular events. Therefore, this medication is useful for blood sugar management and cardiovascular health.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps control blood sugar. However, it may cause a rare side effect known as severe lactic acidosis, requiring caution. Specifically, patients with impaired kidney function or severe infections or dehydration should be cautious when using this medication. Additionally, there is a risk of hypoglycemia when taken with insulin or sulfonylurea drugs, so caution is advised. Kidney function should be regularly monitored to ensure it is normal, and if it falls below a certain threshold, the medication should be discontinued. Patients with acute illnesses or those scheduled for surgery should stop taking this medication for a certain period before and after the surgery. It is safest for pregnant or breastfeeding women to avoid this medication. This medication may increase the risk of urinary tract infections or genital infections, so medical consultation should be sought immediately if symptoms arise. Care should be taken to avoid dehydration or fluid loss while taking this medication, especially for the elderly who should manage their hydration status carefully. Long-term use of this medication may lower vitamin B12 levels, necessitating blood tests for monitoring. Furthermore, excessive alcohol consumption should be avoided while taking this medication as it may increase the risk of lactic acidosis. It is unclear how this medication may affect driving or operation of machinery, so caution is advised. If there are any abnormalities or side effects while taking this medication, medical consultation should be sought immediately.

Side effects

Hypoglycemia, urinary tract infection, genital infection, increased urination, decreased and deficiency of vitamin B12, ketoacidosis, lactic acidosis, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, taste disorders, pruritus, rash, urticaria, erythema multiforme, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, perineal necrosis, vulvar lichen, vulvovaginitis, balanitis, fluid volume loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), chronic gastritis, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastrointestinal disorders, gastroesophageal reflux disease, oral discomfort, salivary gland pain, headache, sensory impairment, orthostatic dizziness, dizziness, cerebral infarction, drowsiness, CNS origin vertigo, fatigue, peripheral edema, facial swelling, peripheral swelling, fever, facial swelling, chills, strange sensations, edema, pain, tenderness at the puncture site, vascular stent stenosis, vascular stent thrombosis, chest pain, asthenia, ankle fracture, epicondylitis, facial bone fracture, ligament injury, arthralgia, back pain, musculoskeletal pain, bone loss, urinary stones, weight loss, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, double vision, hypertension, myocardial infarction, insomnia, anxiety, acute cholecystitis, autoimmune hepatitis, cholelithiasis, otalgia, orthostatic vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, diabetic foot, dermoid cyst, seborrheic dermatitis, atopic dermatitis, circular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, ocular discomfort, ocular hyperemia, pathological myopia, retinal detachment, retinal crystals, retinal venous occlusion, lattice retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, asthma, age-related dyspnea, wet cough, allergic rhinitis, residual phlegm, cough, skin laceration, bruise, rib fracture, concussion, corneal abrasion, fall, hand fracture, iliotibial band syndrome, open globe injury, pelvic fracture, road traffic accident, splenic injury, sternum fracture, angina, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, atherosclerosis, deep vein thrombosis, diabetic vascular disorders, peripheral artery occlusive disease, unstable angina, hypercholesterolemia, dyslipidemia, vitamin D deficiency, nasopharyngitis, soft tissue infection, pneumonia, upper respiratory tract infection, nasopharyngitis, herpes zoster, amnesia, carotid stenosis, diabetic neuropathy, facial paralysis, intracranial aneurysm, memory impairment, neuralgia, Parkinsonism, polyneuropathy, sensory disorders, drowsiness, CNS origin vertigo, fever, vascular stent stenosis, vascular stent thrombosis, alanine aminotransferase elevation, aspartate aminotransferase elevation, weight gain, electrocardiogram abnormality, hemoglobin decrease, hemoglobin increase, Helicobacter pylori test positive, urine red blood cells positive, ureterolithiasis, acute kidney injury, chronic kidney disease, hematuria, overactive bladder, kidney mass, urinary retention, urinary pain, abnormal urination, cervical inflammation, hyperglycemia, diabetes mellitus, hyponatremia, dermoid cyst, seborrheic dermatitis, atopic dermatitis, circular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, ocular discomfort, ocular hyperemia, pathological myopia, retinal detachment, retinal crystals, retinal venous occlusion, lattice retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, asthma, age-related dyspnea, wet cough, allergic rhinitis, residual phlegm, cough, skin laceration, rib fracture, iliotibial band syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius to preserve the drug's efficacy and safety.

Appearance and packaging

Appearance

Biconvex oval film-coated tablet with a yellow color that has a brownish tint

Package unit

10 tablets/box [(10 tablets/PTP)×1], 60 tablets/box [(10 tablets/PTP)×6], 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.